Pacira BioSciences, Inc. (PCRX) — Cash Flow Quality Index
Pacira BioSciences, Inc. (PCRX) has a Cash Flow Quality Index of 8.81x as of March 2026. Operating cash flow of $25.68 Million exceeds net income of $2.92 Million, indicating high earnings quality where cash backs reported profits. Explore PCRX long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pacira BioSciences, Inc. Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Pacira BioSciences, Inc. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Pacira BioSciences, Inc. tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Pacira BioSciences, Inc. (2015–2025)
Year-by-year earnings quality comparison for Pacira BioSciences, Inc.. For live market cap and the full company financial profile, see Pacira BioSciences, Inc. stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 21.61x | $151.99 Million | $7.03 Million | ▲ +486.2% |
| 2023 | 3.69x | $154.65 Million | $41.95 Million | ▼ -59.6% |
| 2022 | 9.13x | $145.27 Million | $15.91 Million | ▲ +204.9% |
| 2021 | 2.99x | $125.72 Million | $41.98 Million | ▲ +465.7% |
| 2020 | 0.53x | $77.03 Million | $145.52 Million | ▼ -96.6% |
| 2015 | 15.62x | $29.00 Million | $1.86 Million | — |